Protective effect of intrathecal ketorolac in spinal cord ischemia in rats: a microdialysis study

Authors: Hsieh; Cheng1; Chan2; Chang2; Liu3; Wong

Source: Acta Anaesthesiologica Scandinavica, Volume 51, Number 4, April 2007 , pp. 410-414(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background: 

The prevention of ischemic paraplegia after thoracoabdominal aortic surgery is challenging for both anesthesiologists and surgeons. In a previous study, we showed that intrathecal ketorolac pre-treatment protects rats against ischemic spinal cord injury. In the present study, using a microdialysis method, we investigated whether this neuroprotective effect was related to changes in the spinal cord release of nitric oxide (NO) or the excitatory amino acids (EAAs) aspartate and glutamate. Methods: 

Rats were randomized to receive either intrathecal saline or ketorolac 60 μg (10 rats per group), 1 h before spinal cord ischemic injury induced by balloon inflation of a 2F Fogarty catheter in the thoracic aorta with maintenance of the proximal arterial blood pressure at 40 mmHg for 11 min, followed by reperfusion. Another 10 animals were used as the sham-operated control group. Ischemic injury was assessed by hind limb motor function. Cerebrospinal fluid dialysates were collected at baseline (before ischemia) and at 1, 2, 3, 4, 6, 12 and 24 h after the start of reperfusion, and were analyzed for EAAs using high-performance liquid chromatography and for NO metabolites using an NO analyzer. Results: 

The results showed that intrathecal ketorolac attenuated spinal cord ischemic injury. Dialysate concentrations of NO and EAAs were increased after spinal cord ischemia, and this effect was inhibited by intrathecal administration of ketorolac. Conclusions: 

The results of this study suggest that the neuroprotective effect of intrathecal ketorolac in spinal cord ischemia in rats may be caused by a decrease in the spinal cord release of NO and EAAs.

Keywords: excitatory amino acids; ketorolac; microdialysis; nitric oxide; protection; spinal cord ischemia

Document Type: Research article

DOI: 10.1111/j.1399-6576.2006.01258.x

Affiliations: 1: Institute of Neuroregeneration, Veterans General Hospital and National Yang-Ming University, Shipai, Taipei, Taiwan 2: Department of Anesthesiology 3: Nociceptive Signal Transduction Laboratory, Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Neihu, Taipei, Taiwan

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A